Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

2012; Elsevier BV; Volume: 121; Issue: 11 Linguagem: Inglês

10.1182/blood-2012-08-450742

ISSN

1528-0020

Autores

Paul G. Richardson, David S. Siegel, Rachid Baz, Susan L. Kelley, Nikhil C. Munshi, Jacob P. Laubach, Daniel M. Sullivan, Melissa Alsina, Robert Schlossman, Irene M. Ghobrial, Deborah Doss, Nora Loughney, Laura McBride, Elizabeth Bilotti, Palka Anand, Lisa Nardelli, Sandra Wear, Gail Larkins, Min Chen, M. Zaki, Christian Jacques, Kenneth C. Anderson,

Tópico(s)

Peptidase Inhibition and Analysis

Referência(s)